Risk-adapted therapy for relapsed and refractory lymphoma using ICE chemotherapy Craig Moskowitz Pages: 9 - 12
Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue Fredrick B. Hagemeister Pages: 13 - 20
Microencapsulated, CYP2B1-transfected cells activating ifosfamide at the site of the tumor: the magic bullets of the 21st century Matthias LöhrFrank HummelBrian Salmons Pages: 21 - 24
Gemcitabine, ifosfamide and Navelbine (GIN): a platinum-free combination in advanced non-small-cell lung cancer (NSCLC) Editta BaldiniAndrea ArdizzoniCarmelo Tibaldi Pages: 25 - 28
